- Home
- CELU vs ACCS Comparison
CELU vs ACCS Comparison
Compare CELU & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELU | ACCS |
|---|---|---|
| Founded | 2016 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3M | 18.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CELU | ACCS |
|---|---|---|
| Price | $1.71 | $5.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 10.8M | 28.7K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 139.36 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $26,550,000.00 | $22,619,000.00 |
| Revenue This Year | N/A | $7.40 |
| Revenue Next Year | $76.00 | $8.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.56 | $4.74 |
| 52 Week High | $2.55 | $11.35 |
Technical Indicators
Market Signals| Indicator | CELU | ACCS |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 43.42 |
| Support Level | $1.13 | $4.74 |
| Resistance Level | $2.42 | $5.83 |
| Average True Range (ATR) | 0.36 | 0.35 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 52.94 | 48.98 |
Price Performance
Historical ComparisonAbout CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
About ACCS ACCESS Newswire Inc.
ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.